[go: up one dir, main page]

NO20083708L - 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer - Google Patents

4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer

Info

Publication number
NO20083708L
NO20083708L NO20083708A NO20083708A NO20083708L NO 20083708 L NO20083708 L NO 20083708L NO 20083708 A NO20083708 A NO 20083708A NO 20083708 A NO20083708 A NO 20083708A NO 20083708 L NO20083708 L NO 20083708L
Authority
NO
Norway
Prior art keywords
thiazole
phenyl
carboxylmides
carboxylic acid
plk1 inhibitors
Prior art date
Application number
NO20083708A
Other languages
English (en)
Inventor
Paul Gillespie
Nader Fotouhi
Christophe Michoud
Jianping Cai
Jr Robert Alan Goodnow
John Frederick Boylan
Kang Le
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20083708L publication Critical patent/NO20083708L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Oppfinnelsen angår forbindelser med formel (1) og farmasøytisk akseptable salter derav, metoder for fremstillingen derav og metoder for anvendelse derav.
NO20083708A 2006-02-27 2008-08-28 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer NO20083708L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77696406P 2006-02-27 2006-02-27
PCT/EP2007/051541 WO2007096315A1 (en) 2006-02-27 2007-02-19 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors

Publications (1)

Publication Number Publication Date
NO20083708L true NO20083708L (no) 2008-09-23

Family

ID=38051896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083708A NO20083708L (no) 2006-02-27 2008-08-28 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer

Country Status (19)

Country Link
US (1) US7504513B2 (no)
EP (1) EP1991543A1 (no)
JP (1) JP2009528284A (no)
KR (1) KR101060539B1 (no)
CN (1) CN101415704A (no)
AR (1) AR059621A1 (no)
AU (1) AU2007217575A1 (no)
BR (1) BRPI0710473A2 (no)
CA (1) CA2642921A1 (no)
CR (1) CR10206A (no)
EC (1) ECSP088700A (no)
IL (1) IL193481A0 (no)
MA (1) MA30260B1 (no)
MX (1) MX2008010884A (no)
NO (1) NO20083708L (no)
RU (1) RU2008138163A (no)
TW (1) TW200745097A (no)
WO (1) WO2007096315A1 (no)
ZA (1) ZA200807074B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8412867B2 (en) * 2007-06-08 2013-04-02 Nec Corporation Semiconductor integrated circuit and filter and informational delivery method using same
WO2009094224A1 (en) 2008-01-25 2009-07-30 Millennium Pharmaceuticals, Inc. Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
KR101707669B1 (ko) * 2008-04-17 2017-02-16 더 존스 홉킨스 유니버시티 약제-내성 종양에서 화학요법제 활성을 증강시키는 ｏｎ01910.ｎａ
CN102150210B (zh) * 2008-09-10 2013-04-10 数据激光有限公司 数据存储介质
WO2010077295A1 (en) * 2008-12-09 2010-07-08 King Faisal Specialist Hospital & Research Centre Substituted tricyclic heterocycles and uses to treat tumors and proliferative disorders
EP2379543A2 (en) * 2008-12-18 2011-10-26 F. Hoffmann-La Roche AG Thiazolyl-benzimidazoles
US9090601B2 (en) * 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
CN102395585A (zh) * 2009-01-30 2012-03-28 米伦纽姆医药公司 杂芳基化合物和其作为pi3k抑制剂的用途
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TW201217365A (en) 2010-08-11 2012-05-01 Millennium Pharm Inc Heteroaryls and uses thereof
US8859768B2 (en) 2010-08-11 2014-10-14 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US9062038B2 (en) 2010-08-11 2015-06-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
JP2013542941A (ja) 2010-10-13 2013-11-28 ミレニアム ファーマシューティカルズ， インコーポレイテッド ヘテロアリールおよびその使用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322429A (en) 1980-09-16 1982-03-30 Eli Lilly And Company Isoxazolylbenzamides as insecticides
US4818270A (en) 1986-08-28 1989-04-04 Monsanto Company 2-(Heteroamino)-4,5-substituted-oxazole/thiazole compounds as herbicide antidotes, compositions and use
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
CZ2003591A3 (cs) 2000-08-10 2003-06-18 Pharmacia Italia S. P. A. Bicyklopyrazoly účinné jako kinázové inhibitory, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
GB0102687D0 (en) 2001-02-02 2001-03-21 Pharmacia & Upjohn Spa Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
US20050107316A1 (en) 2002-02-22 2005-05-19 Klaus Strebhardt Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent
AU2003211385A1 (en) * 2002-02-28 2003-09-09 Takeda Chemical Industries, Ltd. Azole compounds
JP2003321460A (ja) * 2002-02-28 2003-11-11 Takeda Chem Ind Ltd アゾール化合物
KR100972131B1 (ko) 2002-02-28 2010-07-26 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 증식성 질병 치료용 아미노-치환（ｅ）-2,6-디알콕시스티릴 4-치환-벤질설폰
EP1501794A1 (de) 2002-05-03 2005-02-02 Schering Aktiengesellschaft Thiazolidinone und ihre verwendung als polo like kinase inhibitoren
US6906186B1 (en) 2002-07-30 2005-06-14 Isis Pharmaceuticals, Inc. Antisense modulation of polo-like kinase expression
JP2006505522A (ja) * 2002-08-08 2006-02-16 スミスクライン ビーチャム コーポレーション チオフェン化合物
WO2004046317A2 (en) 2002-11-14 2004-06-03 Massachusetts Institue Of Technology Products and processes for modulating peptide-peptide binding domain interactions
JPWO2004043936A1 (ja) 2002-11-14 2006-03-09 協和醗酵工業株式会社 Ｐｌｋ阻害剤
JP3837670B2 (ja) 2002-12-12 2006-10-25 富士通株式会社 データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
GB0302220D0 (en) 2003-01-30 2003-03-05 Cyclacel Ltd Use
ATE433447T1 (de) 2003-02-20 2009-06-15 Smithkline Beecham Corp Pyrimiidinverbindungen
ES2326808T3 (es) 2003-04-01 2009-10-20 Smithkline Beecham Corporation Compuestos de imidazotriazina para el tratamiento de enfermedades cancerosas.
DK1641780T3 (da) 2003-06-24 2009-02-02 Pfizer Prod Inc Fremgangsmåder til fremstilling af 1-[(benzimidazol-1yl)quinolin-8-yl]-piperidin-4-ylamin-derivater
WO2005019193A2 (en) 2003-08-20 2005-03-03 Smithkline Beecham Corporation Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk)
CA2542880A1 (en) 2003-10-21 2005-05-12 Cyclacel Limited Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
DE10351744A1 (de) 2003-10-31 2005-06-16 Schering Ag Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
JP2007519720A (ja) 2004-01-28 2007-07-19 スミスクライン ビーチャム コーポレーション チアゾール化合物

Also Published As

Publication number Publication date
KR101060539B1 (ko) 2011-08-30
CN101415704A (zh) 2009-04-22
US7504513B2 (en) 2009-03-17
ECSP088700A (es) 2008-09-29
WO2007096315A1 (en) 2007-08-30
AU2007217575A1 (en) 2007-08-30
US20070203210A1 (en) 2007-08-30
RU2008138163A (ru) 2010-04-10
KR20080090550A (ko) 2008-10-08
MA30260B1 (fr) 2009-03-02
TW200745097A (en) 2007-12-16
JP2009528284A (ja) 2009-08-06
BRPI0710473A2 (pt) 2011-08-16
CA2642921A1 (en) 2007-08-30
IL193481A0 (en) 2009-05-04
CR10206A (es) 2008-09-22
MX2008010884A (es) 2008-09-03
ZA200807074B (en) 2009-10-28
EP1991543A1 (en) 2008-11-19
AR059621A1 (es) 2008-04-16

Similar Documents

Publication Publication Date Title
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
NO20082496L (no) Pyrazinderivater
EA201000805A1 (ru) Бис-(сульфониламино)производные в терапии 066
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
NO20090628L (no) Pyridizinon derivativater
TW200728307A (en) Novel spirochromanone derivatives
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
EA201001013A1 (ru) Бис(сульфониламино)производные для применения в терапии
MX2011013771A (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17.
WO2009066152A3 (en) Haloallylamine inhibitors of ssao/vap-1 and uses therefor
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20084418L (no) Azolopyridin-3-on derivater som inhibitorer av endoteliallipase
NO20083726L (no) Spiroindolinon derivater
NO20066055L (no) Pyridinderivater
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
NO20082159L (no) Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser
EA201100503A1 (ru) Глюкозидные производные и их применения
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
NO20082096L (no) Azaindol-2-karboksamidderivativer
EA201001747A1 (ru) Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
NO20080033L (no) Kinolinderivater som NK3-antagonister
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application